Zyvox - written all over

Some patients have Zyvox written all over them.

With proven efficacy, excellent tissue penetration, and clear and consistent dosing, count on Zyvox to treat MRSA in patients with nosocomial pneumonia whose conditions are complicated by renal insufficiency.

---

Brand name: Zyvox
Generic name/category: Linezolid
Company: Pfizer
Country/Market: USA, North America
Indication(s)/Category: nosocomial pneumonia
Target: Healthcare Professionals (HCP)
Tagline: Confidence to face complexity
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: Chest - December 1, 2009

To see all of this brand's ads on AdPharm, click here
From Wikipedia:
Linezolid (INN) is a synthetic antibiotic used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics. A member of the oxazolidinone class of drugs, linezolid is active against most Gram-positive bacteria that cause disease, including streptococci, vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA). The main indications of linezolid are infections of the skin and soft tissues and pneumonia (particularly hospital-acquired pneumonia), although off-label use for a variety of other infections is becoming popular. Linezolid is marketed by Pfizer under the trade names Zyvox (in the United States, United Kingdom, Australia, and several other countries), Zyvoxid (in Europe), and Zyvoxam (in Canada and Mexico). Generics are also available in India, such as Linospan (Cipla).

More on Wikipedia